Published in J Exp Med on April 01, 1977
Acquisition of murine major histocompatibility complex gene products by schistosomula of Schistosoma mansoni. J Exp Med (1978) 1.98
Reversal of infectious mononucleosis-associated suppressor T cell activity by D-mannose. J Exp Med (1983) 0.93
Sequential change of carbohydrate antigen associated with differentiation of murine leukemia cells: i-I antigenic conversion and shifting of glycolipid synthesis. Proc Natl Acad Sci U S A (1983) 0.86
Co-purification of galactosyltransferases from chick-embryo liver. Biochem J (1985) 0.84
Ia antigens in serum during different murine infections. Infect Immun (1979) 0.78
Monosaccharide inhibition of cytotoxic T-cell function: demonstration of clone-specific effects. Immunology (1988) 0.75
The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization. Adv Immunol (1975) 9.19
The biochemistry of plant lectins (phytohemagglutinins). Annu Rev Biochem (1973) 5.67
Two genes in the major histocompatibility complex control immune response. Nature (1975) 4.08
Evidence for the expression of Ia (H-2-associated) antigens on thymus-derived lymphocytes. J Exp Med (1974) 3.56
Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor. J Exp Med (1974) 3.29
The nature of an antigenic determinant. J Immunol (1966) 2.85
Properties of antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. I. In vivo activity and immunochemical characterization. J Exp Med (1975) 2.78
The helminthosporoside-binding protein of sugarcane. Its properties and relationship to susceptibility to the eye spot disease. J Biol Chem (1973) 2.50
Structural and serological properties of murine Ia alloantigens. Transplant Rev (1976) 2.35
Genetic and biochemical aspects of human blood-group A-, B-, H-, Le-a- and Le-b-specificity. Br Med Bull (1969) 2.20
Structure of the carbohydrate units of IgA1 immunoglobulin. II. Structure of the O-glycosidically linked oligosaccharide units. J Biol Chem (1974) 2.17
Membrane molecules determined by the H-2 associated immune response region: isolation and some properties. Proc Natl Acad Sci U S A (1974) 2.17
Expression of individual Ia specificities on T and B cells. I. Studies with mitogen-induced blast cells. J Exp Med (1976) 2.08
Serologic and genetic aspects of murine Ia antigens. Transplant Rev (1976) 2.02
Cell surface glycosyltransferases. Biochim Biophys Acta (1975) 1.63
Evidence for more than one Ia antigenic specificity on molecules determined by the I-A subregion of the mouse major histocompatibility complex. J Immunol (1976) 1.49
Biochemical properties of histocompatibility antigens. Annu Rev Genet (1970) 1.38
Involvement of carbohydrate in the immunochemical determinant area of HL-A substances. Nat New Biol (1971) 1.17
The dual role of sialic acid in the hepatic recognition and catabolism of serum glycoproteins. Biochem Soc Symp (1974) 0.96
Determination of lymphocyte division by flow cytometry. J Immunol Methods (1994) 11.48
Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature (1978) 6.59
The consultant episode: an unhelpful measure. BMJ (1992) 5.35
A procedure for removing red cells and dead cells from lymphoid cell suspensions. J Immunol Methods (1975) 4.22
NuA4, an essential transcription adaptor/histone H4 acetyltransferase complex containing Esa1p and the ATM-related cofactor Tra1p. EMBO J (1999) 4.14
The genetic testing of children. Working Party of the Clinical Genetics Society (UK) J Med Genet (1994) 4.12
X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat Genet (1996) 3.90
Mortality in systemic lupus erythematosus. Arthritis Rheum (2006) 3.61
Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells. Nature (1990) 3.57
Efficient purchasing. BMJ (1993) 3.31
Resistance and susceptibility of mice to bacterial infection: genetics of listeriosis. Infect Immun (1978) 3.24
New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J Immunol Methods (1990) 3.19
Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med (1999) 3.06
Yeast SAS silencing genes and human genes associated with AML and HIV-1 Tat interactions are homologous with acetyltransferases. Nat Genet (1996) 3.02
Measuring readmission rates. BMJ (1990) 3.01
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
Should we test children for "adult" genetic diseases? Lancet (1990) 2.97
Resistance and susceptibility of mice to bacterial infection: course of listeriosis in resistant or susceptible mice. Infect Immun (1978) 2.65
T-cell lines producing antigen-specific suppressor factor. Nature (1978) 2.63
Guidelines, enthusiasms, uncertainty, and the limits to purchasing. BMJ (1995) 2.59
Immune response to chemically modified flagellin. II. Evidence for a fundamental relationship between humoral and cell-mediated immunity. J Exp Med (1971) 2.47
The relationship between humoral and cell-mediated immunity. Transplant Rev (1972) 2.43
Regulation of the immune response. I. Suppression of delayed-type hypersensitivity by T cells from mice expressing humoral immunity. Eur J Immunol (1976) 2.36
B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse. J Exp Med (1979) 2.28
T-T interactions in the induction of suppressor and helper T cells: analysis of membrane phenotype of precursor and amplifier cells. J Exp Med (1977) 2.22
Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. J Exp Med (1981) 2.18
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum (2007) 2.18
Why do women attend familial breast cancer clinics? J Med Genet (2000) 2.13
Fetal medicine and ultrasonography: a genetic perspective. Clin Radiol (1992) 2.12
Development of a Cosmetic Procedure Screening Questionnaire (COPS) for Body Dysmorphic Disorder. J Plast Reconstr Aesthet Surg (2011) 2.10
Comparison of the manoeuvrability and ease of use of the Ambu aScope and Olympus re-usable fibrescope in a manikin. Anaesthesia (2011) 2.08
Can readmission rates be used as an outcome indicator? BMJ (1990) 2.07
Murine lymphocyte surface antigens. Adv Immunol (1979) 2.04
Run for your money. Health Serv J (1993) 2.00
Guidelines for reporting clinical features in cases with MECP2 mutations. Brain Dev (2001) 1.99
In vivo and in vitro effects of monoclonal antibody to Ly antigens on immunity to infection. Cell Immunol (1982) 1.97
An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum (2005) 1.96
Spatial and temporal operation of the Scotia Sea ecosystem: a review of large-scale links in a krill centred food web. Philos Trans R Soc Lond B Biol Sci (2007) 1.95
Adenovirus-induced alterations of the cell growth cycle: a requirement for expression of E1A but not of E1B. J Virol (1983) 1.93
Randomized trial of a specialist genetic assessment service for familial breast cancer. J Natl Cancer Inst (2000) 1.92
A sensitive rosetting method for detecting subpopulations of lymphocytes which react with alloantisera. J Immunol Methods (1978) 1.91
Immune response to chemically modified flagellin. 3. Enhanced cell-mediated immunity during high and low zone antibody tolerance to flagellin. J Exp Med (1972) 1.90
Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2010) 1.84
Improved diagnosis of Becker muscular dystrophy by dystrophin testing. Neurology (1989) 1.81
Low zone tolerance to bacterial flagellin in adult rats: a possible role for antigen localized in lymphoid follicles. Proc Natl Acad Sci U S A (1968) 1.81
The lymphocyte surface. I. Relation between Fc receptors, C'3 receptors and surface immunoglobulin. Proc R Soc Lond B Biol Sci (1974) 1.80
Inflammatory process in murine lymphocytic choriomeningitis is maximal in H-2K or H-2D compatible interactions. J Immunol (1976) 1.78
The lymphocyte surface. II. Separation of Fc receptor, C'3 receptor and surface immunoglobulin-bearing lymphocytes. Proc R Soc Lond B Biol Sci (1974) 1.76
Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci U S A (1993) 1.76
Preferential induction of cell-mediated immunity by chemically modified sheep erythrocytes. Eur J Immunol (1972) 1.73
Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med (1995) 1.70
The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children. Clin Exp Allergy (2000) 1.70
Which T cells cause graft rejection? Transplantation (1982) 1.69
Effect of safety packaging on aspirin ingestion by children. Pediatrics (1979) 1.69
Automated colorimetric assay for T cell cytotoxicity. J Immunol Methods (1983) 1.68
"B"-cell stimulation of allogeneic T-cell proliferation in mixed lymphocyte cultures. Nat New Biol (1973) 1.68
Molecular mechanisms of late apoptotic/necrotic cell clearance. Cell Death Differ (2009) 1.66
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum (2008) 1.65
Source of catalysis in the lactate dehydrogenase system. Ground-state interactions in the enzyme-substrate complex. Biochemistry (1994) 1.64
Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing. Eur J Immunol (1992) 1.64
Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet (2000) 1.61
Immune response to chemically modified flagellin. I. Induction of antibody tolerance to flagellin by acetoacetylated derivatives of the protein. J Exp Med (1971) 1.60
MUC1 cross-reactive Gal alpha(1,3)Gal antibodies in humans switch immune responses from cellular to humoral. Nat Med (1998) 1.58
Mouse macrophage beta subunit (CD11b) cDNA for the CR3 complement receptor/Mac-1 antigen. Immunogenetics (1990) 1.58
Cleavage of bacterial flagellin with cyanogen bromide. Antigenic properties of the protein fragments. Biochem J (1969) 1.53
Separation and functional analysis of subpopulations of lymphocytes bearing complement and Fc receptors. Transplant Rev (1975) 1.53
Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection. J Immunother (2001) 1.52
Ir gene function in an I-A subregion mutant B6.C-H-2bm12. J Exp Med (1981) 1.51
Herpes zoster in general practice. J R Coll Gen Pract (1975) 1.51
Protein determination on an automatic spectrophotometer. Anal Biochem (1982) 1.50
Cellular origins of co-stimulator (IL2) and its activity in cytotoxic T lymphocyte responses. J Immunol (1980) 1.48
Tissue expression, structure and function of the murine Ly-6 family of molecules. Immunol Cell Biol (1995) 1.48
Detection and significance of occult metastases in node-negative breast cancer. Br J Surg (1993) 1.47
Peptide mimics of a tumor antigen induce functional cytotoxic T cells. Nat Biotechnol (1998) 1.46
The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46. Immunology (1990) 1.45
Parental origin and germline mosaicism of deletions and duplications of the dystrophin gene: a European study. Hum Genet (1992) 1.44
A simple and rapid acrylamide gel method for estimating the molecular weights of proteins and protein subunits. Anal Biochem (1970) 1.44
Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. BMJ (1995) 1.44
Lesions in the blood supply of the papilla in experimental analgesic nephropathy. Med J Aust (1968) 1.42
Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res (1991) 1.41
Molecular composition of the peri-islet basement membrane in NOD mice: a barrier against destructive insulitis. Diabetologia (2008) 1.41
Specificity, Ly phenotype, and H-2 compatibility requirements of effector cells in delayed-type hypersensitivity responses to murine influenza virus infection. J Exp Med (1980) 1.41
Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein. J Clin Invest (1997) 1.40
In vivo analysis of Pim-1 deficiency. Nucleic Acids Res (1993) 1.40
Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Immunol Rev (1994) 1.40
Mucins: structure, function, and associations with malignancy. Bioessays (1992) 1.40
Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci U S A (1993) 1.40
The cutaneous features of tuberous sclerosis: a population study. Br J Dermatol (1996) 1.40
Molecular cloning of a human immunoglobulin G Fc receptor. Proc Natl Acad Sci U S A (1988) 1.38
Screening, ethics, and the law. BMJ (1993) 1.38
Micrometastases in esophagogastric cancer: high detection rate in resected rib segments. Gastroenterology (1999) 1.38
Identification of active-site residues of the pro-metastatic endoglycosidase heparanase. Biochemistry (2000) 1.37
Partial primary structure of the T4 antigens of mouse and sheep: assignment of intrachain disulfide bonds. Proc Natl Acad Sci U S A (1986) 1.36
Deposits of immunoglobulin and fibrin in human allografted kidneys. Lancet (1968) 1.35
Monoclonal antibodies to the murine Ly-2.1 cell surface antigen. Immunology (1982) 1.35
CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients. J Med Genet (2006) 1.35
Cleavage of bacterial flagellin with cyanogen bromide. Chemical and physical properties of the protein fragments. Biochem J (1969) 1.34
Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum (2008) 1.34
Discrimination of suppressor T cells of humoral and cell-mediated immunity by anti-Ly and anti-Ia sera. Cell Immunol (1977) 1.33